Influence of Potentially Inappropriate Medication Use on Older Australians' Admission to Emergency Department Short Stay.

Hoa T M Tran, Cristina Roman, Gary Yip, Michael Dooley, Mohammed S Salahudeen, Biswadev Mitra
Author Information
  1. Hoa T M Tran: Department of Pharmacy and Emergency and Trauma Centre, Alfred Hospital, Melbourne, VIC 3004, Australia. ORCID
  2. Cristina Roman: Department of Pharmacy and Emergency and Trauma Centre, Alfred Hospital, Melbourne, VIC 3004, Australia.
  3. Gary Yip: Department of General Medicine, Alfred Hospital, Melbourne, VIC 3004, Australia.
  4. Michael Dooley: Department of Pharmacy, Alfred Hospital, Melbourne, VIC 3004, Australia.
  5. Mohammed S Salahudeen: School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia. ORCID
  6. Biswadev Mitra: Emergency and Trauma Centre, Alfred Hospital, Melbourne, VIC 3004, Australia. ORCID

Abstract

Older people in the emergency department (ED) often pose complex medical challenges, with a significant prevalence of Polypharmacy and potentially inappropriate medicines (PIMs) in Australia. A retrospective analysis of 200 consecutive patients aged over 65 years admitted to the emergency short stay unit (ESSU) aimed to identify Polypharmacy (five or more regular medications), assess PIM prevalence, and explore the link between pre-admission PIMs and ESSU admissions. STOPP/START version 2 criteria were used for the PIM assessment, with an expert panel categorizing associated risks. Polypharmacy was observed in 161 patients (80.5%), who were older (mean age 82 versus 76 years) and took more regular medications (median 9 versus 3). One hundred and eighty-five (92.5%) patients had at least one PIM, 81 patients (40.5%) had STOPP PIMs, and 177 patients (88.5%) had START omissions. Polypharmacy significantly correlated with STOPP PIM (OR 4.8; 95%CI: 1.90-12.1), and for each additional medication the adjusted odds of having a STOPP PIM increased by 1.20 (95%CI: 1.11-1.28). Nineteen admissions (9.5%) were attributed to one or more PIMs (total 21 PIMs). Of these PIMs, the expert panel rated eight (38%) as high risk, five (24%) as moderate risk, and eight (38%) as low risk for causing hospital admission. The most common PIMs were benzodiazepines, accounting for 14 cases (73.6%). Older ESSU-admitted patients commonly presented with Polypharmacy and PIMs, potentially contributing to their admission.

Keywords

References

  1. PLoS One. 2019 Jul 26;14(7):e0219898 [PMID: 31348784]
  2. Age Ageing. 2008 Mar;37(2):138-41 [PMID: 18349010]
  3. Pharm Pract (Granada). 2007;5(2):78-84 [PMID: 25214922]
  4. Br J Clin Pharmacol. 2021 Nov;87(11):4150-4172 [PMID: 34008195]
  5. Aging Clin Exp Res. 2019 Nov;31(11):1661-1673 [PMID: 30632078]
  6. Aust Prescr. 2018 Jun;41(3):73-77 [PMID: 29922001]
  7. J Gen Intern Med. 2020 Nov;35(11):3323-3332 [PMID: 32820421]
  8. Ann Emerg Med. 2003 May;41(5):668-77 [PMID: 12712034]
  9. BMC Geriatr. 2022 Jan 11;22(1):44 [PMID: 35016636]
  10. Front Pharmacol. 2023 Nov 07;14:1273655 [PMID: 38026998]
  11. Arch Intern Med. 2009 Nov 23;169(21):1952-60 [PMID: 19933955]
  12. Acad Emerg Med. 2023 Apr;30(4):410-419 [PMID: 36794336]
  13. Curr Aging Sci. 2019;12(2):121-154 [PMID: 31096900]
  14. Eur Addict Res. 2022;28(5):377-381 [PMID: 36041417]
  15. Am J Health Syst Pharm. 2022 Sep 22;79(19):1652-1662 [PMID: 35596269]
  16. Eur Geriatr Med. 2023 Aug;14(4):625-632 [PMID: 37256475]
  17. J Clin Pharm Ther. 2016 Apr;41(2):158-69 [PMID: 26990017]
  18. Med J Aust. 2010 Aug 2;193(3):149-53 [PMID: 20678042]
  19. Age Ageing. 2017 May 1;46(3):366-372 [PMID: 27940568]
  20. CMAJ. 2008 Jun 3;178(12):1563-9 [PMID: 18519904]
  21. J Manag Care Spec Pharm. 2019 May;25(5):573-577 [PMID: 31039057]
  22. Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):56-63 [PMID: 19561441]
  23. Age Ageing. 2015 Mar;44(2):213-8 [PMID: 25324330]
  24. Br J Clin Pharmacol. 2020 Dec;86(12):2414-2423 [PMID: 32374041]
  25. Front Pharmacol. 2021 Jul 30;12:676020 [PMID: 34393774]
  26. J Clin Pharm Ther. 2016 Aug;41(4):414-8 [PMID: 27255463]
  27. Curr Clin Pharmacol. 2015;10(3):213-21 [PMID: 26265487]
  28. Expert Opin Drug Saf. 2022 Jul;21(7):985-994 [PMID: 35180833]
  29. Emerg Med Australas. 2008 Jun;20(3):216-20 [PMID: 18062781]
  30. Australas J Ageing. 2016 Dec;35(4):262-265 [PMID: 26970209]
  31. Age Ageing. 2022 May 1;51(5): [PMID: 35639800]
  32. BMJ Open. 2014 Dec 08;4(12):e006544 [PMID: 25488097]
  33. Perm J. 2019;23:18-161 [PMID: 30624198]
  34. QJM. 2013 Nov;106(11):1009-15 [PMID: 23836694]
  35. J Am Geriatr Soc. 2019 Apr;67(4):674-694 [PMID: 30693946]
  36. Br J Clin Pharmacol. 2010 May;69(5):543-52 [PMID: 20573091]
  37. Int J Clin Pharm. 2019 Jun;41(3):757-766 [PMID: 31028596]
  38. J Gen Intern Med. 2012 Mar;27(3):304-10 [PMID: 21975822]
  39. J Clin Med. 2020 Jan 27;9(2): [PMID: 32012721]
  40. Int J Emerg Med. 2011 Jun 02;4(1):22 [PMID: 21635734]
  41. Australas J Ageing. 2019 Sep;38(3):206-210 [PMID: 30868694]
  42. Drugs Aging. 2018 Jan;35(1):43-60 [PMID: 29350335]
  43. JAMA Intern Med. 2022 May 1;182(5):534-542 [PMID: 35343999]
  44. Emerg Med Australas. 2017 Apr;29(2):143-148 [PMID: 28111931]
  45. Ann Fam Med. 2019 May;17(3):257-266 [PMID: 31085530]
  46. Intern Emerg Med. 2017 Mar;12(2):213-220 [PMID: 27075646]
  47. Int J Environ Res Public Health. 2023 Jan 13;20(2): [PMID: 36674208]

Word Cloud

Created with Highcharts 10.0.0PIMspatientsPIM5%polypharmacy1OlderemergencypotentiallySTOPPmedicationriskprevalenceinappropriateyearsESSUfiveregularmedicationsadmissionsexpertpanelPolypharmacyolderversus9one95%CI:eight38%admissionpeopledepartmentEDoftenposecomplexmedicalchallengessignificantmedicinesAustraliaretrospectiveanalysis200consecutiveaged65admittedshortstayunitaimedidentifyassessexplorelinkpre-admissionSTOPP/STARTversion2criteriausedassessmentcategorizingassociatedrisksobserved16180meanage8276tookmedian3Onehundredeighty-five92least814017788STARTomissionssignificantlycorrelatedOR4890-12additionaladjustedoddsincreased2011-128Nineteenattributedtotal21ratedhigh24%moderatelowcausinghospitalcommonbenzodiazepinesaccounting14cases736%ESSU-admittedcommonlypresentedcontributingInfluencePotentiallyInappropriateMedicationUseAustralians'AdmissionEmergencyDepartmentShortStaydeprescribingreviewpopulation

Similar Articles

Cited By

No available data.